GRCE
Grace Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
4.84 / 10Overall Score
NeturalInvestment Rating
4.84 / 10Overall Score
NeturalInvestment Rating
Is GRCE a Buy, Sell, or Hold?
- Based on a composite score of 4.84/10, we rate GRCE as a Netural. Our analysis breaks down into 6.60/10 for Fundamentals, 5.43/10 for Technicals, and 3.66/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of GRCE?
Is GRCE undervalued or overvalued?
What is the analyst consensus for GRCE?
Is GRCE a Buy, Sell, or Hold?
- Based on a composite score of 4.84/10, we rate GRCE as a Netural. Our analysis breaks down into 6.60/10 for Fundamentals, 5.43/10 for Technicals, and 3.66/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is GRCE undervalued or overvalued?
Technical Analysis of GRCE?
What is the analyst consensus for GRCE?
